Clinical characteristics, drug resistance, and treatment outcomes among tuberculosis patients with diabetes in Peru

International Journal of Infectious Diseases

Volumn 17, Issue 6, 2013, Pages

  Magee, M J ^a   Bloss, E ^b   Shin, S S ^c,d   Contreras, C ^d   Huaman, H Arbanil ^e   Ticona, J Calderon ^e   Bayona, J ^c,d   Bonilla, C ^e   Yagui, M ^f,g   Jave, O ^e   Cegielski, J P ^b  

^a EMORY UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c PARTNERS IN HEALTH   (United States)

^d SOCIOS EN SALUD   (Peru)

^e MINISTERIO DE SALUD   (Peru)

^f INSTITUTO NACIONAL DE SALUD   (Peru)

^g UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

Author keywords

Diabetes; Multi drug resistance; Peru; Tuberculosis

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DRUG RESISTANT TUBERCULOSIS; DRUG SENSITIVITY; FEMALE; HIGH RISK PATIENT; HUMAN; INSULIN TREATMENT; LABORATORY; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; OUTCOME ASSESSMENT; PERU; PROSPECTIVE STUDY; SPUTUM CULTURE;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; DIABETES MELLITUS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PERU; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84877157462     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.12.029     Document Type: Article

References (38)

1. World Health Organization. Global tuberculosis control: WHO report 2011. Geneva: WHO; 2011.
2. World Health Organization. Diabetes. Fact sheet No. 312. Geneva: WHO; 2011.
3. Baker M.A., Lin H.H., Chang H.Y., Murray M.B. The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. Clin Infect Dis 2012, 54:818-825.
4. Dooley K.E., Chaisson R.E. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009, 9:737-746.
5. Jeon C.Y., Murray M.B. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008, 5:e152.
6. Lonnroth K., Castro K.G., Chakaya J.M., Chauhan L.S., Floyd K., Glaziou P., Raviglione M.C. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 2010, 375(9728):1814-1829.
7. International Diabetes Federation International Diabetes Federation diabetes atlas 2009, IDF, Brussels. 4th ed.
8. Magee M.J., Blumberg H.M., Narayan K.M. Commentary: Co-occurrence of tuberculosis and diabetes: new paradigm of epidemiological transition. Int J Epidemiol 2011, 40:428-431.
9. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva: WHO; 2010.
10. Chang J.T., Dou H.Y., Yen C.L., Wu Y.H., Huang R.M., Lin H.J., et al. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance. J Formos Med Assoc 2011, 110:372-381.
11. Singh R., Gothi D., Joshi J. Multidrug resistant tuberculosis: role of previous treatment with second line therapy on treatment outcome. Lung India 2007, 24:54-57.
12. Aragon J., Litonjua A., Tupasi T., Quelapio I. Prevalence of type 2 diabetes among multi-drug resistant tuberculosis (MDR-TB) patients seen in Makati Medical Center under the directly observed therapy plus (DOTS PLUS) program. Philippine Journal of Internal Medicine 2003, 41:7-10.
13. Tanrikulu A.C., Hosoglu S., Ozekinci T., Abakay A., Gurkan F. Risk factors for drug resistant tuberculosis in southeast Turkey. Trop Doct 2008, 38:91-93.
14. Garcia F., Solis J., Calderon J., Luque E., Zacarias E. Prevalence of diabetes mellitus and related risk factors in an urban population. Revista de la Sociedad Peruana de Medicina Interna 2007, 20:90-94.
15. Bashar M., Alcabes P., Rom W.N., Condos R. Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest 2001, 120:1514-1519.
16. Fisher-Hoch S.P., Whitney E., McCormick J.B., Crespo G., Smith B., Rahbar M.H., et al. Type 2 diabetes and multidrug-resistant tuberculosis. Scand J Infect Dis 2008, 40:888-893.
17. Park S.W., Shin J.W., Kim J.Y., Park I.W., Choi B.W., Choi J.C., et al. The effect of diabetic control status on the clinical features of pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis 2012, 7:1305-1310.
18. World Health Organization. Global tuberculosis control: WHO report 2010. Geneva: WHO; 2010.
19. Barcelo A. Diabetes in the Americas. Epidemiol Bull 2001, 22:1-3.
20. Shin S.S., Yagui M., Ascencios L., Yale G., Suarez C., Quispe N., et al. Scale-up of multidrug-resistant tuberculosis laboratory services, Peru. Emerg Infect Dis 2008, 14:701-708.
21. Ministerio de Salud Norma tecnica de salud para el control de la tuberculosis 2006, Ministerio de Salud, Lima, Peru.
22. Shin S.S., Yagui M., Ascencios L., Yale G., Suarez C., Quispe N., et al. Targeted drug-resistance testing strategy for multidrug-resistant tuberculosis detection, Lima, Peru, 2005-2008. Emerg Infect Dis 2011, 17:432-440.
23. Shin S.S., Asencios L., Yagui M., Yale G., Suárez C., Bayona J., et al. Impact of rapid drug susceptibility testing for tuberculosis: program experience in Lima, Peru. Int J Tuberc Lung Dis 2012, 16:1538-1543.
24. World Health Organization Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: a report of a WHIO/IDF consultation 2006, WHO, Geneva.
25. World Health Organization Guidelines for the programmatic management of drug-resistant tuberculosis 2006, WHO, Geneva.
26. World Health Organization Treatment of tuberculosis: guidelines for national programmes 2009, WHO, Geneva. 4th ed.
27. Dooley K.E., Tang T., Golub J.E., Dorman S.E., Cronin W. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 2009, 80:634-639.
28. Ruslami R., Aarnoutse R.E., Alisjahbana B., van der Ven A.J., van Crevel R. Implications of the global increase of diabetes for tuberculosis control and patient care. Trop Med Int Health 2010, 15:1289-1299.
29. Nissapatorn V., Kuppusamy I., Jamaiah I., Fong M.Y., Rohela M., Anuar A.K. Tuberculosis in diabetic patients: a clinical perspective. Southeast Asian J Trop Med Public Health 2005, 36(Suppl 4):213-220.
30. Ponce-De-Leon A., Garcia-Garcia Md Mde L., Garcia-Sancho M.C., Gomez-Perez F.J., Valdespino-Gomez J.L., Olaiz-Fernandez G., et al. Tuberculosis and diabetes in southern Mexico. Diabetes Care 2004, 27:1584-1590.
31. Restrepo B.I., Fisher-Hoch S.P., Crespo J.G., Whitney E., Perez A., Smith B., McCormick J.B. Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect 2007, 135:483-491.
32. International Standards for Tuberculosis Care (ISTC) 2006, Tuberculosis Coalition for Technical Assistance, Tuberculosis Coalition for Technical Assistance, The Hague.
33. Singla R., Khan N., Al-Sharif N., Ai-Sayegh M.O., Shaikh M.A., Osman M.M. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis 2006, 10:74-79.
34. Wang C.S., Yang C.J., Chen H.C., Chuang S.H., Chong I.W., Hwang J.J., et al. Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiol Infect 2009, 137:203-210.
35. Bacakoglu F., Basoglu O.K., Cok G., Sayiner A., Ates M. Pulmonary tuberculosis in patients with diabetes mellitus. Respiration 2001, 68:595-600.
36. Alisjahbana B., Sahiratmadja E., Nelwan E.J., Purwa A.M., Ahmad Y., Ottenhoff T.H., et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 2007, 45:428-435.
37. Perez-Guzman C., Torres-Cruz A., Villarreal-Velarde H., Salazar-Lezama M.A., Vargas M.H. Atypical radiological images of pulmonary tuberculosis in 192 diabetic patients: a comparative study. Int J Tuberc Lung Dis 2001, 5:455-461.
38. Chiang C.Y., Lee J.J., Yu M.C., Enarson D.A., Lin T.P., Luh K.T. Tuberculosis outcomes in Taipei: factors associated with treatment interruption for 2 months and death. Int J Tuberc Lung Dis 2009, 13:105-111.